One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v128.22.102.102
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 40 |
Affiliation: Monash University, Vanderbilt University, Cornell University, Presbyterian Hospital, New York Hospital Queens, NewYork–Presbyterian Hospital, University of Pittsburgh, University Medical Center Hamburg-Eppendorf, University of Kansas, University of Bologna, Fred Hutch Cancer Center, University of Washington, Calvary Mater Newcastle Hospital, AbbVie (United States)Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged ≥65 Years with Acute Myeloid Leukemia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
